NCT05464251 Prospective Analysis of Spinal Epidural Abscess
| NCT ID | NCT05464251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Francis Farhadi |
| Condition | Spinal Epidural Abscess |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-07-12 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-07-12 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.
Eligibility Criteria
Inclusion Criteria: * All patient with ICD codes for pyogenic vertebral osteomyelitis, discitis, and spinal epidural abscess will be reviewed for inclusion. Exclusion Criteria: * Patients unwilling or unable to attend follow up appointments.
Contact & Investigator
Francis Farhadi, MD, PhD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT05464251 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Epidural Abscess. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05464251 currently recruiting?
Yes, NCT05464251 is actively recruiting participants. Contact the research team at francis.farhadi@uky.edu for enrollment information.
Where is the NCT05464251 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05464251 clinical trial?
NCT05464251 is sponsored by Francis Farhadi. The principal investigator is Francis Farhadi, MD, PhD at University of Kentucky. The trial plans to enroll 200 participants.